Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic androgen and anabolic steroid belonging to the class of androgens and derivatives. It is a methylated derivative of dihydrotestosterone (DHT), structurally characterized as a 3-hydroxylated C19 steroid hormone. The compound is considered experimental and illicit, with no approved medical indications or clinical use. Its mechanism of action is presumed to be similar to other anabolic steroids—binding to the androgen receptor as an agonist—thereby promoting masculinization and anabolic effects such as increased muscle mass[1][2]. There are no known approved pharmaceutical products containing this substance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 17alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane.